Abstract
The COVID‐19 pandemic quickly led to an abundance of publications and recommendations, despite a paucity of information on how COVID‐19 affects children with cancer. This created a dire need for a trusted resource with curated information and a space for the pediatric oncology community to share experiences. The Global COVID‐19 Observatory and Resource Center for Childhood Cancer was developed, launched, and maintained by the International Society of Pediatric Oncology and St. Jude Children's Research Hospital. The three components (Resource Library, Global Registry, and Collaboration Space) complement each other, establishing a mechanism to generate and transfer knowledge rapidly throughout the community.
Keywords: collaboration, COVID‐19, knowledge transfer, pediatric oncology
Abbreviations
- GCORCCC
The Global COVID‐19 Observatory and Resource Center for Childhood Cancer
- SIOP
International Society of Pediatric Oncology
- SJCRH
St. Jude Children's Research Hospital.
1. INTRODUCTION
After rapidly spreading across the globe, COVID‐19 officially became a pandemic on March 11, 2020. 1 Initial reports suggested that patients with comorbidities were at higher risk, causing concern that children with cancer were at risk of developing severe infection. 2 Furthermore, measures to mitigate the spread of the virus, such as delaying medical procedures and travel restrictions, were anticipated to disturb the continuity of pediatric cancer care. 3 It was also anticipated that the effects of the pandemic on health systems would amplify existing obstacles to caring for children with cancer. 3
Since the beginning of the pandemic, a deluge of information regarding disease characteristics and possible management strategies was disseminated. This infodemic, an overabundance of information during an epidemic, 4 has posed challenges never encountered before and was an early concern. 5 The rapid spread of information and misinformation, potentiated by social media platforms, presented a public health challenge, confusing and overwhelming healthcare professionals and lay public alike.
In response to the need for a trusted resource with curated, reliable information and a platform to share experiences for the pediatric oncology community, the International Society of Pediatric Oncology (SIOP) and St. Jude Children's Research Hospital (SJCRH) created the Global COVID‐19 Observatory and Resource Center for Childhood Cancer (GCORCCC). The GCORCCC was launched as an open‐access website (covid19childhoodcancer.org) on April 15, 2020.
2. GENERAL OVERVIEW OF THE RESOURCE CENTER
The GCORCCC comprises three main elements: Resource Library, Global Registry, and Collaboration Space, outlined below. As of October 20, 2020, the GCORCCC has 64,980 page views by 32,295 unique users from 164 countries (Figure 1). Additionally, to address questions related to pediatric cancer care during the pandemic in a live and interactive way, a series of webinars entitled COVID Conversations have been hosted. To date, 11 sessions directed at various aspects of cancer care and disciplines, including pediatric oncologists, nurses, surgeons, radiation oncologists, nongovernmental organizations, parents, and survivors, have been held. Regionally focused sessions were also held for Northern Italy and Spain, India and Pakistan, Latin America, and Africa. On average, the webinars have been attended by 337 people from 70 countries.
2.1. Resource library
The Resource Library contains updated curated peer‐reviewed manuscripts, guidance documents, and links relevant to the multidisciplinary care of children with cancer during COVID‐19. 6 Publications are reviewed and assessed for relevance weekly for inclusion. 7 We prioritize the dissemination of accurate data and quickly identify and address misinformation or conflicting reports. Only peer‐reviewed articles are included, as unvetted scientific information, such as preprints, were identified as a risk for misinformation for providers. 8 , 10
The sections of the Resource Library are as follows: COVID‐19 and Pediatric Oncology, General COVID‐19 Information, Treatment, Prevention, For Healthcare Providers, and For Patients and Families. Each section provides a collection of publications, guidance documents, recorded webinars, and relevant links.
To address the needs of healthcare professionals during this unprecedented time, resources focusing on leadership, self‐care, and resiliency are also included in the Resource Library. Additionally, a subsection specifically aimed at nurses, with literature and guidance documents, was developed. The Pediatric Oncology Nursing during COVID‐19 Fact Sheet summarizes the most relevant guidance for caring for children with cancer and is available in six languages as a quick bedside reference. Finally, a section with resources for patients and families aids bedside providers in educating and navigating patients and families toward trusted, accurate sources of information.
2.2. Registry
At the beginning of the pandemic, the natural history of COVID‐19 in children and adolescents with cancer was unknown. To gain an accurate picture of the burden of COVID‐19 among this patient population, we developed the Global COVID‐19 Registry. Healthcare providers worldwide were invited to voluntarily report any patient (under 19 years of age) with a malignancy or history of hematopoietic stem cell transplant at the time of a laboratory‐confirmed SARS‐CoV‐2 infection. The Registry was approved by the SJCRH Institutional Review Board.
As of December21, 2020, 1228 cases from 46 countries have been reported. Using aggregate data, we created an interactive data visualization dashboard to provide updates in a dynamic format (Figure 2). The data visualization allows providers to filter cases by variables such as underlying diagnosis, cancer treatment, and COVID‐19 outcomes.
2.3. Collaboration space
Creating an opportunity to bring the global community of healthcare professionals together is an essential component of the GCORCCC. The Collaboration Space provides a forum for healthcare professionals to interact and share their experiences and questions about caring for children with cancer during the COVID‐19 pandemic. The Collaboration Space has language translation capabilities, making it accessible to a large number of providers globally. Here, users are also able to access content, such as videos, blog posts, and live events.
Through sharing experiences, providers can support and learn from each other. From the Frontlines is a blog series published to highlight unique accounts of childhood cancer providers navigating COVID‐19 around the world. To date, the blog features stories from 24 providers in 19 countries. These providers discuss the challenges their teams have faced and innovative solutions they have employed to continue to treat children with cancer during the pandemic. Currently, there are 1300 total active users registered in the Collaboration Space who have connected and interacted over 36,000 times with content elements.
3. DISCUSSION
A rapidly evolving pandemic poses many challenges in caring for children with cancer. The GCORCCC established a mechanism to generate and transfer knowledge for the pediatric oncology community during a global pandemic and infodemic. Through its various elements, users can access relevant information to help them adapt and respond to the rapidly shifting situation.
Academic institutions and professional societies should play central roles in the accurate and timely dissemination of information. For professionals caring for children with cancer, the sharing of experiences from regions that were affected early in the pandemic was essential for formulating the initial responses to the evolving pandemic. 11 , 12 , 13 In addition, guidance for the management of COVID‐19 for different patient populations was generated by government agencies and professional societies with remarkable speed. 14 , 15 , 16 Importantly, information sufficiency has been linked to less stress and worry amongst health care professionals. 17 For this reason, a resource like the GCORCCC can support individuals to decrease burn out and improve resilience. This effort brought colleagues together and facilitated a sense of community in these trying times, in an innovative approach to addressing global challenges in pediatric cancer care. Many organizations attempted to compile listing of resources that are relevant to their specific populations, but few of them also sought to create knowledge about COVID‐19 in their populations to add to the evidence‐based literature.
4. CONCLUSION
At a time of exceptionally high stakes for children with cancer, the multi‐stakeholder collaboration that led to the GCORCCC represents a framework for global cooperative efforts in the future. SIOP and SJCRH formed a partnership aimed at disseminating the GCORCCC widely and rapidly throughout the global network, leveraging the strengths of both organizations. This platform shows that novel, dynamic information resources can help provide guidance to frontline providers across the globe, facilitating the rapid sharing and adoption of new information in highly dynamic situations. The collaborations built through this rapid multidisciplinary implementation and global dissemination process provide a foundation upon which the global community can collectively build to ultimately improve outcomes for all children with cancer everywhere.
In memoriam: This manuscript is dedicated to Dr. Arturo Moreno, past president of SLAOP/SIOP Latin America, a tireless advocate for children with cancer in Mexico, Latin America, and the world.
CONFLICT OF INTEREST
The authors declare that there is no conflict of interest.
Moreira DC, Sniderman E, Mukkada S, et al. The Global COVID‐19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global. Pediatr Blood Cancer. 2021;68:e28962. 10.1002/pbc.28962
[Correction added on 04 March 2021 after online publication: The author name Lane Faughan should be corrected as Lane Faughnan (n added)]
REFERENCES
- 1.WHO. WHO Director‐General's opening remarks at the media briefing on COVID‐19, 11 March 2020 . 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. Accessed October 20, 2020.
- 2. Liang W, Guan W, Chen R, et al. Cancer patients in SARS‐CoV‐2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335‐337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Bouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez‐Galindo C, Pritchard‐Jones K. Early advice on managing children with cancer during the COVID‐19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020;67:e28327. [DOI] [PubMed] [Google Scholar]
- 4. Galvão Jane. COVID‐19: the deadly threat of misinformation. Lancet Infect Dis. 2020; 10.1016/s1473-3099(20)30721-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. WHO . Munich Security Conference, 15 February 2020. https://www.who.int/director-general/speeches/detail/munich-security-conference. Accessed October 20, 2020.
- 6. WHO . Developing global norms for sharing data and results during public health emergencies. 2 September 2015. https://www.who.int/medicines/ebola-treatment/data-sharing_phe/en. Accessed October 20, 2020. [DOI] [PMC free article] [PubMed]
- 7. Tangcharoensathien V, Calleja N, Nguyen T, et al. Framework for managing the COVID‐19 infodemic: methods and results of an online, crowdsourced WHO technical consultation. J Med Internet Res. 2020;22:e19659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID‐19: a multinational registry analysis. Lancet. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 9. Mehra MR, Ruschitzka F, Patel AN. Retraction‐Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID‐19: a multinational registry analysis. Lancet. 2020;395:1820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Voss A, Coombs G, Unal S, et al. Publishing in face of the COVID‐19 pandemic. International Journal of Antimicrobial Agents. 2020;56(1):106081. 10.1016/j.ijantimicag.2020.106081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Yang C, Li C, Wang S, National Clinical Research Center for Child Health and Disorders and Children's Oncology Committee of Chinese Research Hospital Association . Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection. Pediatr Blood Cancer. 2020;67:e28248. [DOI] [PubMed] [Google Scholar]
- 12. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID‐19 in children with cancer in New York City. JAMA Oncol. 2020. 10.1001/jamaoncol.2020.2028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Vasquez L, Sampor C, Villanueva G, et al. Early impact of the COVID‐19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020;21:753‐755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Sullivan M, Bouffet E, Rodriguez‐Galindo C, et al. The COVID‐19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020;67:e28409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Janssens GO, Mandeville HC, Timmermann B, et al. A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID‐19 pandemic or other crises. Radiother Oncol. 2020;148:216‐222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Verbruggen LC, Wang Y, Armenian SH, et al. Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: a statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2020:e28702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Goulia P, Mantas C, Dimitroula D, Mantis D, Hyphantis T. General hospital staff worries, perceived sufficiency of information and associated psychological distress during the A/H1N1 influenza pandemic. BMC Infect Dis. 2010;10:322. [DOI] [PMC free article] [PubMed] [Google Scholar]